SS
ALDX icon

SBI Securities’s Aldeyra Therapeutics ALDX Stock Holding History

SBI Securities’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$444 Hold
263
– – ﹤0.01% 2928
2025
Q4 		$1.36K Hold
263
– – ﹤0.01% 2528
2025
Q3 		$1.37K Hold
263
– – ﹤0.01% 2568
2025
Q2 		$1.01K Hold
263
– – ﹤0.01% 2676
2025
Q1 		$1.51K Buy
263
+11
+4% +$65 ﹤0.01% 2419
2024
Q4 		$1.26K Buy
+252
New +$1.29K ﹤0.01% 2504

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SBI Securities's ALDX Position: Q1 2026 in Review

SBI Securities held its Aldeyra Therapeutics (ALDX) position steady in Q1 2026 at 263 shares worth $444. The position accounts for ﹤0.01% of the portfolio, ranked #2928.

SBI Securities first reported a position in ALDX in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.51K in Q1 2025. 126 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.

  • SBI Securities held 263 shares of Aldeyra Therapeutics worth $444 as of Q1 2026.
  • SBI Securities left its Aldeyra Therapeutics share count unchanged in Q1 2026.
  • Aldeyra Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #2928 holding.
  • SBI Securities first reported a position in Aldeyra Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Aldeyra Therapeutics position peaked at $1.51K in Q1 2025.
  • 126 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.